Replies to post #9803 on Momenta Pharmaceuticals, Inc. (MNTA)

[io_io]

end-game for mLov?.... This Amp instance may end up being the best thing happen to MNTA in LT persepctive.

I don't think you get it just yet.

Even with an "en-banc", at the most, MNTA might eventually get a royalty from WPI/Ampha. You read the prognostications and board surveys for likelihood of a 20% royalty.

Now think - first, what would a 20% royalty from WPI/Ampha be really worth?

And then, to my original question last year, how could they possibly dream of a 20% royalty from WPI/Ampha if the entire profit margin enjoyed by WPI/Ampha is 10% or less?

And with a "process" patent too? That's all they have, this is generic medicine folks. A year ago I wrote 2% here as a MNTA royalty goal and you will be lucky to see it, if ever.